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Correction to: Dexamethasone for adult
patients with a symptomatic chronic
subdural haematoma (Dex-CSDH) trial:
study protocol for a randomised controlled
trial
Angelos G. Kolias1,2*†, Ellie Edlmann1,2*†, Eric P. Thelin1,3, Diederik Bulters4, Patrick Holton4, Nigel Suttner5,
Kevin Owusu-Agyemang5, Yahia Z. Al-Tamimi6, Daniel Gatt6, Simon Thomson7, Ian A. Anderson7, Oliver Richards7,
Peter Whitfield8, Monica Gherle8, Karen Caldwell2, Carol Davis-Wilkie9, Silvia Tarantino2, Garry Barton10,
Hani J. Marcus11, Aswin Chari12, Paul Brennan13, Antonio Belli14, Simon Bond9,15, Carole Turner1,2,
Lynne Whitehead16, Ian Wilkinson9, Peter J. Hutchinson1,2* and British Neurosurgical Trainee Research Collaborative
(BNTRC) and Dex-CSDH Trial Collaborators
Correction to: Trials (2018) 19:670
https://doi.org/10.1186/s13063-018-3050-4
After publication of the original article [1], the authors
notified that that one of the BNTRC institutional collab-
orator names was misspelled. Both incorrect and correct
spellings are presented below.
 Originally published name
Ardalan Zolnouria
 Correct name spelling
Ardalan Zolnourian
Author details
1Department of Clinical Neurosciences, University of Cambridge, Cambridge,
Biomedical Campus, Cambridge CB2 0QQ, UK. 2Division of Neurosurgery,
Addenbrooke’s Hospital, Box 167, Cambridge CB2 0QQ, UK. 3Department of
Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. 4Wessex
Neurological Centre, University Hospital Southampton NHS Foundation Trust,
Tremona Rd, Southampton, Hampshire SO16 6YD, UK. 5Institute of
Neurosciences, Queen Elizabeth University Hospital, 1345 Govan Road,
Glasgow, UK. 6Department of Neurosurgery, Sheffield Teaching Hospitals
NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.
7Department of Neurosurgery, Leeds General Infirmary, Great George Street,
Leeds LS1 3EX, UK. 8Southwest Neurosurgical Centre, Plymouth University
Hospitals NHS trust, Plymouth PL6 8DH, UK. 9Cambridge Clinical Trials Unit
(CCTU), Coton House, Level 6, Cambridge Biomedical Campus, Box 401,
Cambridge CB2 0QQ, UK. 10Norwich Medical School, University of East
Anglia, Norwich NR4 7TJ, UK. 11Imperial College Healthcare NHS Trust, South
Kensington Campus, London SW7 2AZ, UK. 12Royal London Hospital, Barts
Health NHS trust, Whitechapel Road, London E1 1BB, UK. 13Department of
Clinical Neurosciences, University of Edinburgh, Western General Hospitals
NHS Trust, Crewe Road, Edinburgh EH4 2XU, UK. 14NIHR Surgical
Reconstruction and Microbiology Research Centre & University Hospitals
Birmingham NHS Foundation Trust, School of Clinical and Experimental
Medicine, University of Birmingham, Institute of Biomedical Research (West),
Room WX 2.61, Edgbaston, Birmingham B15 2TT, UK. 15MRC Biostatistics Unit,
Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK.
16Clinical Trials Pharmacy, Addenbrooke’s Hospital, Cambridge Biomedical
Campus, Cambridge CB2 0QQ, UK.
Received: 11 March 2019 Accepted: 11 March 2019
Reference
1. Kolias AG, et al. Dexamethasone for adult patients with a symptomatic
chronic subdural haematoma (Dex-CSDH) trial: study protocol for a
randomised controlled trial. Trials. 2018;19:670. https://doi.org/10.1186/
s13063-018-3050-4.
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: ak721@cam.ac.uk; ee291@cam.ac.uk; pjah2@cam.ac.uk
†Angelos G. Kolias and Ellie Edlmann contributed equally to this work.
1Department of Clinical Neurosciences, University of Cambridge, Cambridge,
Biomedical Campus, Cambridge CB2 0QQ, UK
Full list of author information is available at the end of the article
Kolias et al. Trials          (2019) 20:175 
https://doi.org/10.1186/s13063-019-3283-x
